...
首页> 外文期刊>Journal of Pathology: Journal of the Pathological Society of Great Britain and Ireland >Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.
【24h】

Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.

机译:具有基础和肌上皮分化的乳腺癌的形态学和免疫表型分析。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The aim of this study was to assess the morphological characteristics and immunohistochemical profile of breast carcinomas with basal and myoepithelial phenotypes to obtain a better understanding of their biological behaviour and nature. One thousand nine hundred and forty-four invasive breast carcinomas were examined, using tissue microarray (TMA) technology and immunohistochemistry, to identify those tumours that showed basal and myoepithelial phenotypes, and their immunophenotype profile was characterized using a variety of markers. In addition, haematoxylin and eosin-stained sections of these tumours were studied for several morphological parameters. The findings were correlated with patient and tumour characteristics and outcome data. Tumours were classified into two groups: (1) tumours with basal phenotype [expressing one or both basal markers (CK5/6 and/or CK14)] and (2) tumours with myoepithelial phenotype (expressing SMA and/or p63). Group 1 was further subdivided into two subgroups: (A) dominant basal pattern (more than 50% of cells positive) and (B) basal characteristics (10-50% of cells positive). Group 1 tumours constituted 18.6% (8.6% and 10% for groups 1A and 1B, respectively) and group 2 constituted 13.7% of the cases. In both groups, the most common histological types were ductalo specific type, tubular mixed and medullary-like carcinomas; the majority of these tumours were grade 3. There were positive associations with adenoid cystic growth pattern, loss of tubule formation, marked cellular pleomorphism, poorer Nottingham prognostic index, and development of distant metastasis. In addition, associations were found with loss of expression of steroid hormone receptors and FHIT proteins and positive expression of p53 and EGFR. The most common characteristics in group 1 were larger size, high-grade comedo-type necrosis, development of tumour recurrence, and absence of lymph node disease. Group 2 tumours were more common in younger patients and were associated with central acellular zones, basaloid change, and positive E-cadherin protein expression. Group 1 characteristics were associated with both reduced overall survival (OS) [log rank (LR) = 22.5, p < 0.001] and reduced disease-free interval (DFI) (LR = 30.1, p < 0.001), while group 2 characteristics showed an association with OS (LR = 5, p = 0.02) but not with DFI. Multivariate analysis showed that basal, but not myoepithelial, phenotype has an independent value in predicting outcome. Breast cancers with basal and myoepithelial phenotypes are distinct groups of tumours that share some common morphological features and an association with poor prognosis. The basal rather than the myoepithelial phenotype has the strongest relationship with patient outcome.
机译:这项研究的目的是评估具有基础和肌上皮表型的乳腺癌的形态学特征和免疫组化谱,以更好地了解其生物学行为和性质。使用组织微阵列(TMA)技术和免疫组织化学检查了194例浸润性乳腺癌,以鉴定出那些表现出基底和肌上皮表型的肿瘤,并使用多种标记物对它们的免疫表型进行表征。此外,对这些肿瘤的苏木精和伊红染色切片进行了几个形态学参数研究。这些发现与患者和肿瘤特征以及结果数据相关。肿瘤分为两类:(1)具有基础表型[表达一个或两个基础标志物(CK5 / 6和/或CK14)的肿瘤]和(2)具有肌上皮表型的肿瘤(表达SMA和/或p63)。第1组进一步细分为两个亚组:(A)显性基础模式(超过50%的细胞呈阳性)和(B)基础特征(10-50%的细胞呈阳性)。第1组肿瘤占18.6%(第1A和1B组分别为8.6%和10%),第2组占13.7%。在两组中,最常见的组织学类型是导管型/无特定类型,管状混合癌和髓样癌。这些肿瘤大多数为3级。与腺样囊性生长方式,肾小管形成丧失,明显的细胞多形性,诺丁汉预后指标较差以及远处转移的发展呈正相关。此外,发现与类固醇激素受体和FHIT蛋白的表达缺失以及p53和EGFR的阳性表达相关。第一组中最常见的特征是体积较大,高级别粉刺型坏死,肿瘤复发发展和无淋巴结病。第2组肿瘤在年轻患者中更为常见,并与中央无细胞区,基底层改变和E-钙粘蛋白蛋白阳性表达相关。第1组特征与总体生存期(OS)降低[对数秩(LR)= 22.5,p <0.001]和无病间隔期(DFI)降低(LR = 30.1,p <0.001)相关,而第2组特征显示与OS(LR = 5,p = 0.02)的关联,但与DFI无关。多变量分析表明,基础型而非肌上皮型在预测结局方面具有独立的价值。具有基础和肌上皮表型的乳腺癌是不同的肿瘤组,它们具有一些共同的形态特征并与不良预后相关。基础表型而非肌上皮表型与患者预后的关系最强。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号